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Abstract
Background: Dietary intervention success requires strong participant adherence, but very few studies have
examined factors related to both short-term and long-term adherence. A better understanding of predictors of
adherence is necessary to improve the design and execution of dietary intervention trials. This study was designed
to identify participant characteristics at baseline and study features that predict short-term and long-term
adherence with interventions promoting the Mediterranean-type diet (MedDiet) in the PREvención con DIeta
MEDiterránea (PREDIMED) randomized trial.
Methods: Analyses included men and women living in Spain aged 55–80 at high risk for cardiovascular disease.
Participants were randomized to the MedDiet supplemented with either complementary extra-virgin olive oil
(EVOO) or tree nuts. The control group and participants with insufficient information on adherence were excluded.
PREDIMED began in 2003 and ended in 2010. Investigators assessed covariates at baseline and dietary information
was updated yearly throughout follow-up. Adherence was measured with a validated 14-point Mediterranean-type
diet adherence score. Logistic regression was used to examine associations between baseline characteristics and
adherence at one and four years of follow-up.
Results: Participants were randomized to the MedDiet supplemented with EVOO (n = 2,543; 1,962 after exclusions)
or tree nuts (n = 2,454; 2,236 after exclusions). A higher number of cardiovascular risk factors, larger waist
circumference, lower physical activity levels, lower total energy intake, poorer baseline adherence to the 14-point
adherence score, and allocation to MedDiet + EVOO each independently predicted poorer adherence. Participants
from PREDIMED recruiting centers with a higher total workload (measured as total number of persons-years of
follow-up) achieved better adherence. No adverse events or side effects were reported.
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Conclusions: To maximize dietary adherence in dietary interventions, additional efforts to promote adherence
should be used for participants with lower baseline adherence to the intended diet and poorer health status. The
design of multicenter nutrition trials should prioritize few large centers with more participants in each, rather than
many small centers.
Trial registration: This study was registered at controlled-trials.com (http://www.controlled-trials.
com/ISRCTN35739639). International Standard Randomized Controlled Trial Number (ISRCTN): 35739639. Registration
date: 5 October 2005.
Trial design: parallel randomized trial.
Keywords: Dietary adherence, Short-term dietary adherence, Long-term dietary adherence, Mediterranean Diet,
PREDIMED trial, Dietary predictors, Dietary intervention
Background
The global burden of diet-related chronic diseases has
skyrocketed over the last few decades. As rates continue
to rise [1] and food environments become increasingly
obesogenic [2], it is more important than ever to im-
prove understanding of diet-disease relationships and
decrease the risk of chronic disease through diet modifi-
cation. Effective dietary intervention strategies can help
accomplish both of these objectives. The Mediterranean-
type diet (MedDiet) is associated with decreased risk of
all-cause [3, 4] and premature [5, 6] death, cardiovascu-
lar disease [7, 8], type 2 diabetes [9, 10], overweight and
obesity [11, 12], and several cancers [13, 14]. Experimen-
tal interventions and randomized controlled trials
(RCTs) have confirmed these findings [7, 8, 14–19]. It is
very likely that future intervention trials in nutrition will
adopt the paradigm of the Mediterranean food pattern,
as the 2015 Dietary Guidelines for Americans have rec-
ommended [20]. In this context, information about the
predictors of success in interventions using such a food
pattern is very much needed.
Permanent dietary modifications are difficult to
achieve; long-term dietary interventions often have low
adherence [21–26]. Identifying participant characteristics
and study design features that predict long-term adher-
ence will substantially help investigators design dietary
interventions to maximize adherence, achieve sufficient
contrast in nutritional exposures between intervention
arms, and reduce diet-related chronic diseases in target
populations.
A handful of studies have identified predictors of
short-term adherence to dietary interventions [27–35].
Predictors included the female sex [35], older age [27,
29], a non-diabetic [28, 35] and non-depressive status
[34, 36], normal weight [29, 30, 34], higher physical ac-
tivity levels [34, 35], not smoking [35], white ethnicity
[29, 32], higher socioeconomic status [27, 29, 33], and
being married [35]. Only two studies have investigated
predictors of adherence to the MedDiet [35, 37]. PRE-
vención con DIeta MEDiterránea (PREDIMED)
researchers investigated the relationship between base-
line characteristics and MedDiet adherence, but that
study included only a partial sample of the trial and eval-
uated only short-term adherence [35]. Another study
had longer follow-up but lacked a control group [37].
Among the very few studies that have examined long-
term dietary adherence, the outcome was often defined
as meeting weight-loss goals, which is only a proxy for
dietary adherence. Because only sustained, long-term
dietary patterns modify chronic disease risk [38–40], a
better understanding of long-term adherence to healthy
dietary patterns is needed.
The aim of the present study was to identify predictors
of short and long-term adherence with a MedDiet inter-
vention. This study uses data from the PREDIMED trial,
a RCT of the MedDiet for the primary prevention of car-
diovascular disease [41, 42].
Methods
Study population
Details on the PREDIMED design and methods are de-
scribed in detail elsewhere [18, 23, 43]. Briefly, the PRE-
DIMED trial was a multicenter, randomized, controlled,
single-blinded cardiovascular disease prevention trial
conducted in Spain [41]. It was designed to assess the ef-
fects of the MedDiet on cardiovascular disease in 7,447
participants recruited between 2003 and 2009. Eligible
participants were aged 55 to 80 and at high risk for de-
veloping cardiovascular disease (CVD). High risk was
defined as having type 2 diabetes or at least three of the
following major (CVD) risk factors: current smoking,
hypertension, elevated low-density lipoprotein choles-
terol levels, BMI ≥25 kg/m2, or a family history of pre-
mature coronary heart disease (CHD). After providing
written informed consent, participants were randomized
to one of three interventions; a traditional MedDiet sup-
plemented with either complementary extra-virgin olive
oil (EVOO) or tree nuts or a control diet (advice to re-
duce all types of dietary fat). The control group was ex-
cluded from the present analyses because the focus of
Downer et al. International Journal of Behavioral Nutrition and Physical Activity  (2016) 13:67 Page 2 of 16
this study was the adherence with the intervention pro-
moting the MedDiet. Inclusion criteria into this study
are depicted in the flow diagram figure provided below,
along with the CONSORT checklist for randomized tri-
als. The trial ended in 2010, after a median follow-up of
4.8 years, because of the observed benefit of the Med-
Diet compared to the low-fat control diet in the pre-
vention of CVD. Institutional Review Boards at 11
recruiting centers approved the study protocol [44].
No harm or unintended effects were reported in any
arm [41].
When one-year dietary adherence was the outcome of
interest, the present study excluded participants missing
information on any of the 14-point dietary adherence
score items at one year of follow-up (n = 799), leaving
4,198 participants for analysis. When four-year dietary
adherence was the outcome of interest, participants re-
cruited after November 2006 (n = 1,495) were excluded
because subsequent follow-up was less than four years.
Participants who had missing information on any of the
14-point dietary adherence score items at four years of
follow-up were further excluded (n = 1,149), leaving
2,353 participants available for analysis.
Outcome assessment
Registered dietitians conducted quarterly group sessions
and one-on-one in-person interviews to deliver a com-
prehensive motivational educational intervention aimed
at modifying participant eating habits. Dietitians col-
lected detailed dietary information at baseline and yearly
thereafter during follow-up. Individual interviews and
group sessions were conducted every three months
throughout the trial. A previously validated 14-item
Mediterranean Diet Assessment Tool [45] was the pri-
mary method for assessing adherence to the intervention
(Additional file 1: Figure S1). PREDIMED dietitians
assessed participant adherence using this tool during
each visit. A value of 0 (non-compliant) or 1 (compliant)
was assigned to each item [46]. Higher scores reflected
better adherence. High adherence was defined as meet-
ing at least 11 of the 14 items. This cut-point was used
because roughly half of participants complied with 11 or
more items at each follow-up visit.
Covariate assessment
Dietitians administered a validated 137-item food fre-
quency questionnaire (FFQ) at each yearly visit [47],
from which total energy and alcohol intake was com-
puted [48]. Another questionnaire collected information
on sociodemographic variables, lifestyle, and family his-
tory data. A validated Spanish version of the Minnesota
questionnaire [49, 50] was used to assess physical activ-
ity. Investigators reviewed medical records at baseline
and yearly thereafter to assess medical diagnoses. Nurses
measured weight and height using standardized proce-
dures, and blood pressure using a validated [51] semiau-
tomatic oscillometer in triplicate (Omron HEM_705CP).
Primary care doctors assessed participants for new diag-
noses of hypercholesterolemia, hypertension and type 2
diabetes. Definitions for these diagnoses are described
elsewhere [42].
Exposure assessment
Potential baseline predictors of adherence were assessed
based on clinical relevance and findings from previously
published studies. These included sex (male, female), age
(<65 years, ≥65 years), highest educational level attained
(less than primary school, primary school, secondary
school, university or more), occupation (retired, working,
housewife, unemployed or unable to work), marital sta-
tus (married, other), number of people in household,
continuous cardiovascular risk factor score (one point
was assigned for each of the following diagnoses or con-
ditions: type 2 diabetes, hypertension, high blood choles-
terol, family history of premature CHD, depression, and
obesity; scores of 0–1 and 5–6 were collapsed due to
low frequency), individual cardiovascular risk factors
(each of the six factors included in the cardiovascular
risk score were also assessed separately instead of as a
continuous score), systolic blood pressure and diastolic
blood pressure (SBP and DBP, continuous, per 5 mmHg),
waist circumference (continuous, per 5 cm), physical ac-
tivity (tertiles of MET-min/day), smoking status (never,
former, current), total energy intake (quartiles of kcal/
day), alcohol other than wine (low: <10 g/day for men,
<5 for women; moderate: 10–50 for men, 5–10 for
women; high: >50 for men, >10 for women), baseline 14-
point dietary adherence score (<11 points, ≥11 points),
and MedDiet intervention group (mixed nuts, EVOO).
This analysis also evaluated whether the “total work-
load”, measured in person-years of follow-up and an in-
dicator of how many participants a given center delivers
the intervention to throughout follow-up, was associated
with dietary adherence.
Statistical methods
Chi-square tests were used to assess differences in distri-
butions of baseline characteristics between those with
low adherence (<11 points) and high adherence (≥11
points). In Table 2, crude and multivariate-adjusted lo-
gistic regression was used to calculate odds ratios (ORs)
of adherence to the MedDiet at one and four years of
follow-up according to baseline characteristics. Multi-
variate models were adjusted for all potential predictors
of dietary adherence listed above. To calculate p-values
for trend, the median value was assigned to each cat-
egory and the resulting variable was treated as continu-
ous. Quantiles were not treated as ordinal variables to
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account for the fact that the differences in median values
across quantiles were not equal.
Several sensitivity analyses were conducted using
multivariate logistic regression. Analyses looked at asso-
ciations between potential baseline predictors and adher-
ence at two and three years of follow-up (instead of one
and four years), and with ≥10 and ≥12 as alternative cut-
points for dietary adherence (instead of ≥11).
All p-values are two-tailed. Values of ≤0.05 are consid-
ered statistically significant. All statistical analyses were
performed using Stata software (version 12.0, StataCorp
2011, College Station, TX, USA).
Results
Table 1 shows the mean (±SD) or percentage of partici-
pants with high adherence and low adherence (≥11 and
<11 points on 14-point score) after 1-y and 4-y follow-
up across levels of baseline characteristics. 54 % of par-
ticipants complied at one-year follow-up, and 58 % at 4-
y follow-up. The mean (±SD) age at baseline was 66.9
(±6.1) years, and 56.4 % of participants were female. The
following baseline characteristics were associated with
lower adherence at both time points: female sex, a
greater number of cardiovascular risk factors, larger
waist circumference, less physical activity, less total en-
ergy intake, and lower baseline 14-point dietary adher-
ence score. When individual risk factors were assessed,
type 2 diabetes diagnosis and obesity were associated
with poorer adherence at both time points.
Randomization to the MedDiet supplemented with Med-
Diet + EVOO and inclusion at a center following a lower
intervention workload were also correlated with lower
adherence at one and four years. Additional file 2: Table
S5 shows that distributions of baseline characteristics
did not differ depending on time period of enrollment,
with the exception of number of total workload per cen-
ter. Centers that began recruitment after November,
2006 were the only centers with less than 300 partici-
pants. November, 2006 was selected as the cut-point be-
cause participants recruited after this date were followed
for less than four years, and thus were excluded from
analyses where dietary adherence at four years is the
outcome of interest.
Figure 1 provides a summary diagram comparing
multivariate logistic regression results across all primary
and sensitivity analyses.
Short term dietary adherence (one year of follow-up)
Table 2 shows primary results for the association be-
tween potential baseline characteristics and dietary ad-
herence after one and and four years of follow-up. The
following baseline characteristics were associated with
lower dietary adherence at one year of follow-up in
multivariate logistic regression models: the female sex,
working (vs. retired), type 2 diabetes diagnosis, obesity,
larger waist circumference, lower physical activity, lower
total energy intake, and lower 14-point baseline adher-
ence score. Both study design features, randomization to
the MedDiet + EVOO intervention arm, and belonging
to a PREDIMED center that had a lower workload
(fewer person years), were also associated with lower
one-year adherence. In Additional file 2: Table S2, the
dietary adherence score cut-off point is changed from
≥11 to the alternative cut-off points of ≥10 and ≥12. The
majority of predictors of low one-year adherence ob-
served in Table 2, when ≥11 items was the cut-off point,
remained after changing the cut-off point. Exceptions in-
clude obesity (no longer a predictor when either alter-
nate cut-off point was used) and lower energy intake (no
longer a predictor when ≥10 items was the cut-off
point). Additional file 2: Table S4 investigates adherence
at one year of follow-up after excluding those recruited
after November 2006 in order to restrict to the group
that could be analyzed at both time points. A handful of
associations did not hold, likely due to reduced power as
a result of smaller sample size. Associations with lower
one-year adherence that did not hold included the fe-
male gender, working (vs. retired), obesity, lower physical
activity, and lower total energy intake. Baseline predic-
tors of lower one-year adherence that remained signifi-
cant throughout all sensitivity analyses include type 2
diabetes, larger waist circumference, and lower 14-point
baseline adherence score. Both study design features
(randomization to the MedDiet + EVOO intervention
arm and belonging to a PREDIMED center with a lower
workload) were also associated with lower one-year ad-
herence throughout all sensitivity analyses.
Long term dietary adherence (after four years of follow-
up)
Based on the primary analysis in Table 2, the following
baseline characteristics were associated with lower diet-
ary adherence after four years in multivariate logistic re-
gression models: higher total number of cardiovascular
risk factors, specifically type 2 diabetes diagnosis, hyper-
tension, and family history of premature CHD, higher
SBP, lower physical activity levels, lower total energy in-
take, and lower baseline14-point adherence score. Study
design features predicting lower adherence after four
years of follow-up included being in the MedDiet +
EVOO intervention arm and belonging to a PREDIMED
center with a lower workload over follow-up. Table 3 de-
fines four-year adherence as consistently meeting the
criteria for high dietary adherence (≥11 points on 14-
point score) every year throughout the first four years of
follow-up. Results were similar to four-year results in
Table 2. However, with this more stringent definition,
hypertension, higher SBP, and lower energy intake were
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Table 1 Baseline characteristics according to a 14-point dietary adherence score after 1, 4 years of follow-upa
1 Year of Follow-up 4 Years of Follow-up
Adherenceb Low (n = 1925) High (n = 2273) Low (n = 978) High (n = 1375)
Demographic Characteristics c % or mean (SD) p-value % or mean (SD) p-value
Women 59.1 54.6 0.003 61.3 54.6 0.001
Age at Baseline (years) 66.9 (6.1) 66.9 (5.9) 0.68 67.6 (6.2) 66.8 (5.8) 0.005
Educational level
University 7.5 8.8 5.6 8.7
Secondary school 14.8 16.2 15.8 15.0
Primary school 74.7 72.8 75.0 74.8
Less than primary school 3.1 2.2 0.06 3.6 1.6 0.001
Occupation
Retired 51.6 54.6 50.9 53.0
Working 13.1 11.3 10.4 11.4
Housewife 31.5 31.6 35.7 33.0
Unemployed/unable to work 3.8 2.6 0.02 3.0 2.7 0.51
Marital Status
Married 75.9 78.9 75.6 78.9
Single 3.7 3.7 3.5 3.9
Widowed 18.6 15.1 19.1 15.4
Divorced or separated 1.8 2.2 0.22 1.8 1.8 0.12
Number of People in Household 1.7 (1.3) 1.7 (1.4) 0.89 1.6 (1.1) 1.6 (1.5) 0.87
Health-Related Characteristics at Baseline
Number of CVD Risk Factorsc
0-1 5.8 7.6 6.7 10.1
2 27.1 31.5 28.6 33.0
3 39.1 38.7 37.5 37.6
4 21.9 17.7 21.2 16.2
5-6 6.1 4.5 <0.001 6.0 3.1 <0.001
Type 2 diabetes 51.5 44.3 <0.001 53.1 44.6 <0.001
Hypertension 82.2 81. 0.60 82.2 80.2 0.21
Hypercholesterolemia 70.8 73.3 0.06 66.5 69.5 0.12
Family history of premature CHD 24.1 21.9 0.10 24.7 17.5 <0.001
Depression 18.1 16.2 0.10 17.9 14.8 0.04
Obesity 49.0 42.8 <0.001 47.4 42.7 0.02
SBP (mmHg) 148.5 (20.7) 149.7 (20.6) 0.07 148.5 (20.6) 150.5 (20.9) 0.02
DBP (mmHg) 82.9 (10.8) 83.5 (11.1) 0.09 83.3 (11.2) 84.1 (10.9) 0.10
Waist circumference (cm) 101.2 (10.0) 99.1 (10.6) 0.004 100.8 (10.3) 98.7 (10.0) <0.001
Physical activity (MET-min/d)d
T1 (low) 36.1 27.7 36.7 24.7
T2 34.3 33.6 34.0 33.5
T3 (high) 29.6 38.6 <0.001 29.4 41.8 <0.001
Smoking status
Never 62.1 60.7 65.0 61.5
Former 14.7 12.9 12.9 14.1
Current 23.2 26.4 <0.03 22.1 24.4 0.22
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no longer associated with poorer four-year adherence.
After changing the dietary adherence cut-off points to ≥10
and ≥12 items (Additional file 2: Table S2), all associations
between potential predictors and lower four-year adher-
ence remained except for total number of cardiovascular
risk factors (no longer a predictor when cut-off point was
≥10 items), type 2 diabetes diagnosis (no longer a pre-
dictor when cut-point was ≥10 items), higher SBP (no lon-
ger a predictor for either alternative cut-point), and lower
total energy intake (no longer a predictor using either al-
ternative cut-off point). Baseline predictors of lower four-
year adherence that remained significant throughout all
sensitivity analyses included family history of CHD, lower
physical activity, lower baseline 14-point adherence score,
randomization to the MedDiet + EVOO arm, and belong-
ing to a PREDIMED center with a lower workload.
Medium-term adherence (two and three years of follow-up)
Additional file 2: Table S1 shows results for the associ-
ation between potential predictors and adherence at the
alternate time points of two and three years of follow-
up. All characteristics that predicted lower adherence at
both one and four years in the primary analysis multi-
variate logistic regression models (type 2 diabetes diag-
nosis, lower physical activity, lower total energy intake,
lower 14-point adherence score, randomization to the
MedDiet + EVOO arm, and belonging to a PREDIMED
center with a lower workload) also predicted low adher-
ence at both two and three years.
Additional file 2: Table S3 presents results from logistic
regression analyses of the association between MedDiet
intervention (nuts or EVOO) and dietary adherence to
nut and olive oil items on the 14-point dietary adherence
score (≥4 tbsp olive oil per day; olive oil as main culinary
fat; ≥3 servings of nuts per week). Those in the MedDiet
+ EVOO intervention arm had significantly higher odds of
complying with either of the two olive oil items (5 to 10
times the odds) at both one and four years of follow-up.
In contrast, those in the nut intervention group had about
20 times the odds of complying with the nut item.
Discussion
In the PREDIMED trial, baseline characteristics showing
the strongest associations with both low short-term and
low long-term dietary adherence with a MedDiet inter-
vention included a higher number of cardiovascular risk
factors (including specifically type 2 diabetes diagnosis),
larger waist circumference, lower levels of physical activ-
ity, lower baseline dietary adherence, randomization to
the MedDiet + EVOO intervention arm and belonging to
Table 1 Baseline characteristics according to a 14-point dietary adherence score after 1, 4 years of follow-upa (Continued)
Total energy intake (kcal/day)e
Q1 (low) 27.3 21.4 24.6 19.9
Q2 24.5 25.1 24.2 22.9
Q3 25.3 26.5 23.7 27.0
Q4 (high) 23.0 27.1 <0.001 27.6 30.3 0.02
Alcohol other than wine (g/day)
< 10 men, <5 women 57.9 57.6 58.6 57.0
10-50 men, 5–10 women 14.2 14.7 14.7 14.7
> 50 men, > 10 women 27.9 27.7 0.90 26.7 28.3 0.68
14-point adherence scoreb 8.2 (1.8) 9.3 (1.8) <0.001 8.5 (2.0) 9.3 (1.9) <0.001
Intervention Design Features
Intervention Group
MedDiet + EVOO 58.0 49.2 60.7 53.2
MedDiet + Nuts 42.0 50.8 <0.001 39.3 46.8 <0.001
Total workload of center (person-years) f
Q1 (low) 34.4 26.7 25.4 23.3
Q2 27.3 26.8 41.3 33.0
Q3 22.7 32.2 19.9 12.2
Q4 (high) 15.6 15.4 <0.001 13.4 31.5 <0.001
a Those randomized after November 2006 did not have the opportunity to provide information on 4-year adherence. b A validated MedDiet adherence assessment tool was
used. 1 point was added for each item in adherence with the traditional MedDiet. High adherence = adherence with ≥11 items on 14-point dietary adherence score. Low
adherence = adherence with <11 items. c Total CVD risk score was calculated by summing the following CVD risk factors: type 2 diabetes, hypertension, high blood
cholesterol, family history of premature CHD, depression, obesity. d Tertiles of physical activity (MET-min/d): T1: <108; T2: 108–268; T3: ≥268. e Quartiles of energy intake (kcal/
d), by sex: Men: Q1: <2051; Q2: 2051- < 2394; Q3:2934- < 2801; Q4: ≥2801. Women: Q1: <1786; Q2: 1786- < 2109; Q3: 2109- < 2465; Q4: ≥2465. f Measured in quartiles of
person years at center. After 1 Year: Q1: 133- < 352; Q2: 352- < 537; Q3: 537- < 650; Q4: ≥650. After 4 years: Q1: 893- < 1220; Q2: 1220- < 2175; Q3: 2175- < 2384; Q4: ≥2384
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a PREDIMED center with a lower workload, measured by
total person years of follow-up.
Study design
It is not surprising that the total workload (measured in
person years) at a PREDIMED center was associated
with both short-term and long-term adherence; the
workload likely represents the level of experience the re-
search team had with intervention delivery. Similar find-
ings have been observed in hospitals, where quality of
care is often related to number of administered proce-
dures [52]. This finding suggests that multicenter
Fig. 1 Summary of primary and sensitivity analysis results from multivariate logistic regression models investigating predictors of dietary
adherence with the 14-point MedDiet score
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Table 2 Odds of high adherence with the MedDiet intervention at one and four years of follow-upa
OR (95 % CI) for dietary adherence (≥11 vs. <11 points)b
1 Year 4 Years
Demographic Characteristics n Crude p Multivariate p n Crude p Multivariate p
Sex
Men 1820 1.00 (ref) 1.00 (ref) 1103 1.00 (ref) 1.00 (ref)
Women 2378 0.83 (0.73,
0.94)
0.003 0.78 (0.64,
0.96)
0.02 1350 0.76 (0.64,
0.90)
0.001 0.92 (0.69,
1.23)
0.59
Age at baseline (years)
< 65 1627 1.00 (ref) 1.00 (ref) 868 1.00 (ref) 1.00 (ref)
≥ 65 2571 1.01 (0.89,
1.14)
0.90 0.98 (0.80,
1.15)
0.80 1485 0.87 (0.74,
1.04)
0.12 0.90 (0.73,
1.12)
0.36
Educational level
University or higher 339 1.00 (ref) 1.00 (ref) 173 1.00 (ref) 1.00 (ref)
Secondary school 643 0.92 (0.71,
1.20)
0.56 0.97 (0.73,
1.28)
0.83 356 0.61 (0.42,
0.90)
0.01 0.68 (0.46,
1.02)
0.06
Primary School 3109 0.82 (0.65,
1.03)
0.09 0.90 (0.70,
1.15)
0.39 1768 0.64 (0.46,
0.90)
0.009 0.81 (0.57,
1.17)
0.26
Less than primary school 107 0.60 (0.39,
0.92)
0.02 0.87 (0.54,
1.39)
0.55 57 0.29 (0.15,
0.54)
<0.001 0.52 (0.27,
1.01)
0.06
Occupation
Retired 2234 1.00 (ref) 1.00 (ref) 1127 1.00 (ref) 1.00 (ref)
Working 509 0.81 (0.67,
0.98)
0.03 0.77 (0.61,
0.96)
0.02 258 1.04 (0.89,
1.37)
0.75 1.00 (0.72,
1.38)
0.99
Housewife 1324 0.95 (0.83,
1.09)
0.44 1.12 (0.93,
1.33)
0.51 802 0.89 (0.74,
1.06)
0.19 1.03 (0.81,
1.32)
0.80
Unemployed/unable to work 131 0.64 (0.45,
0.91)
0.01 0.14 (0.47,
1.01)
0.06 66 0.87 (0.53,
1.44)
0.59 1.00 (0.58,
1.73)
0.99
Marital Status
Married 3266 1.00 (ref) 1.00 (ref) 1824 1.00 (ref) 1.00 (ref)
Single 157 0.97 (0.70,
1.34)
0.85 1.02 (0.72,
1.43)
0.92 88 1.08 (0.70,
1.68)
0.73 0.93 (0.58,
1.49)
0.76
Widowed 668 0.87 (0.74,
1.03)
0.07 1.00 (0.83,
1.21)
0.99 399 0.77 (0.62,
0.96)
0.02 0.86 (0.67,
1.11)
0.26
Divorced or separated 107 0.75 (0.51,
1.10)
0.15 0.99 (0.66,
1.50)
0.97 42 0.91 (.49, 1.69) 0.76 1.16 (0.60,
2.25)
0.65
Number of people in household 4198 1.00 (0.96,
1.05)
0.89 1.04 (0.99,
1.10)
0.12 2353 1.01 (0.94,
1.07)
0.87 0.99 (0.92,
1.06)
0.70
Health-Related Characteristics at
Baseline
Number of CVD Risk Factors c,d
0–1 285 1.00 (ref) 1.00 (ref) 204 1.00 (ref) 1.00 (ref)
2 1237 0.89 (0.68,
1.15)
0.94 (0.71,
1.25)
734 0.76 (0.55,
1.05)
0.82 (0.58,
1.17)
3 1632 0.76 (0.59,
0.98)
0.94 (0.71,
1.24)
884 0.66 (0.48,
0.91)
0.83 (0.58,
1.18)
4 824 0.62 (0.47,
0.81)
0.87 (0.64,
1.18)
429 0.50 (0.35,
0.71)
0.71 (0.48,
1.04)
5–6 220 0.57 (0.40,
0.81)
<0.001 0.83 (0.56,
1.23)
0.26 102 0.34 (0.21,
0.56)
<0.001 0.47 (0.27,
0.80)
0.009
Individual CVD Risk Factors
Type 2 Diabetes
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Table 2 Odds of high adherence with the MedDiet intervention at one and four years of follow-upa (Continued)
No 2199 1.00 (ref) 1.00 (ref) 1221 1.00 (ref) 1.00 (ref)
Yes 1999 0.75 (0.66,
0.85)
<0.001 0.77 (0.66,
0.88)
<0.001 1132 0.71 (0.60,
0.84)
<0.001 0.74 (0.61,
0.90)
0.003
Hypertension
No 757 1.00 (ref) 1.00 (ref) 447 1.00 (ref) 1.00 (ref)
Yes 3441 0.97 (0.83,
1.13)
0.68 0.89 (0.74,
1.06)
0.20 1906 0.87 (0.71,
1.08)
0.21 0.77 (0.61,
0.99)
0.04
Hypercolesterolaemia
No 1169 1.00 (ref) 1.00 (ref) 748 1.00 (ref) 1.00 (ref)
Yes 3029 1.14 (0.99,
1.30)
0.06 1.06 (0.92,
1.24)
0.42 1605 1.15 (0.96,
1.37)
0.13 1.11 (0.91,
1.36)
0.29
Family history of premature CHD
No 3237 1.00 (ref) 1.00 (ref) 1871 1.00 (ref) 1.00 (ref)
Yes 961 0.89 (0.77,
1.02)
0.10 0.88 (0.75,
1.03)
0.11 482 0.64 (0.53,
0.79)
<0.001 0.63 (0.50,
0.78)
<0.001
Depression
No 3481 1.00 (ref) 1.00 (ref) 1975 1.00 (ref) 1.00 (ref)
Yes 717 0.87 (0.74,
1.02)
0.10 0.97 (0.81,
1.15)
0.71 378 0.79 (0.64,
0.99)
0.04 0.81 (0.63,
1.03)
0.09
Obesity
No 2282 1.00 (ref) 1.00 (ref) 1302 1.00 (ref) 1.00 (ref)
Yes 1916 0.78 (0.69,
0.88)
<0.001 1.12 (0.95,
1.32)
0.17 1051 0.83 (0.70,
0.97)
0.02 1.14 (0.91,
1.43)
0.24
SBP (per 5 mmHg) 4198 1.01 (1.00,
1.03)
0.07 1.00 (0.99,
1.02)
0.70 2353 1.02 (1.00,
1.04)
0.02 1.01 (0.99,
1.04)
0.31
DBP (per 5 mmHg) 4198 1.02 (1.00,
1.05)
0.09 1.02 (0.98,
1.05)
0.38 2353 1.03 (0.99,
1.07)
0.10 1.00 (0.95,
1.05)
0.90
Waist circumference (per 5 cm) 4198 0.90 (0.88,
0.93)
<0.001 0.92 (0.88,
0.95)
<0.001 2353 0.90 (0.87,
0.94)
<0.001 0.97 (0.92,
1.02)
0.22
Physical activity (MET-min/d) c,e
T1 (low) 1332 1.00 (ref) 1.00 (ref) 703 1.00 (ref) 1.00 (ref)
T2 1414 1.28 (1.10,
1.48)
1.13 (0.97,
1.33)
785 1.46 (1.19,
1.80)
1.29 (1.04,
1.60)
T3 (high) 1452 1.70 (1.46,
1.98)
<0.001 1.38 (1.17,
1.63)
<0.001 865 2.12 (1.72,
2.60)
<0.001 1.62 (1.29,
2.04)
<0.001
Smoking Status
Never 2576 1.00 (ref) 1.00 (ref) 1482 1.00 (ref) 1.00 (ref)
Former 574 0.90 (0.75,
1.08)
0.24 0.83 (0.67,
1.04)
0.10 320 1.16 (0.90,
1.48)
0.25 0.97 (0.71,
1.31)
0.83
Current 1048 1.17 (1.01,
1.35)
0.04 1.05 (0.87,
1.26)
0.63 551 1.17 (0.95,
1.42)
0.13 1.01 (0.78,
1.30)
0.96
Total energy intake (kcal/day) c, f
Q1 (low) 1017 1.00 (ref) 1.00 (ref) 568 1.00 (ref) 1.00 (ref)
Q2 1038 1.31 (1.10,
1.56)
1.20 (1.00,
1.45)
858 1.17 (0.92,
1.49)
1.08 (0.84,
1.40)
Q3 1078 1.34 (1.13,
1.59)
1.16 (0.96,
1.39)
363 1.41 (1.11,
1.79)
1.28 (0.99,
1.65)
Q4 (high) 1065 1.50 (1.26,
1.79)
<0.001 1.32 (1.09,
1.58)
0.009 564 1.36 (1.08,
1.72)
0.007 1.27 (0.99,
1.64)
0.04
Alcohol other than wine (g/day)
< 10 men, <5 women 2429 1.00 (ref) 1.00 (ref) 1360 1.00 (ref) 1.00 (ref)
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interventions should recruit participants to fewer centers
with more participants in each, instead of more centers
with fewer participants in each, to maximize effective-
ness and adherence. Streamlining intervention delivery
would have an added benefit of reducing costs. While
this would not explain the difference in adherence, this
would free up resources for increased support for partic-
ipants at risk of poor or suboptimal adherence.
Participants randomized to the MedDiet + EVOO
(compared to tree nuts) had lower dietary adherence.
This is probably because olive oil is a staple ingredient
in the Spanish diet; participants consume olive oil re-
gardless of supplementation from PREDIMED. Nut con-
sumption is not as commonplace. As a result, it is easier
for the nut group to adhere to the olive oil criteria com-
pared to the olive oil group’s ability to adhere to the nut
criteria. Additional file 2: Table S3 shows that interven-
tion group is a much stronger predictor of complying
with the nut adherence item compared to the olive oil
adherence items. This suggests that, for dietary interven-
tions providing participants with complementary food
items, it may be most effective to provide them with
foods that are less commonplace.
Baseline health and lifestyle characteristics
In the present study, many predictors of low adherence
with the MedDiet are indicators of poorer baseline
health, including various cardiovascular risk factors, less
physical activity, and poorer baseline diet. These re-
sults are consistent with previous findings investigat-
ing predictors of adherence with dietary interventions
for reducing fat [29] and carbohydrates [28], family-
level interventions [34], and MedDiet interventions
[35, 37]. Baseline health status may indicate how
much a person values his or her health, which may
moderate one’s motivation to comply with the inter-
vention. Alternatively, some research suggests that in-
dividuals may be more willing or motivated to make
dietary and lifestyle improvements following a medical
diagnosis [53]. These findings do not necessarily
contradict this notion, as many of these indicators of
baseline health are likely long-standing conditions
Table 2 Odds of high adherence with the MedDiet intervention at one and four years of follow-upa (Continued)
10-50 men, 5–10 women 606 1.04 (0.87,
1.24)
0.67 0.88 (0.72,
1.08)
0.21 344 1.03 (0.81,
1.31)
0.81 0.80 (0.61,
1.05)
0.11
> 50 men, >10 women 1163 1.00 (0.87,
1.15)
0.97 0.93 (0.80,
1.09)
0.39 649 1.09 (0.90,
1.32)
0.38 1.03 (0.83,
1.28)
0.77
14-point adherence score a
< 11 3416 1.00 (ref) 1.00 (ref) 1864 1.00 (ref) 1.00 (ref)
≥ 11 782 3.41 (2.85,
4.07)
<0.001 3.25 (2.71,
3.91)
<0.001 489 2.06 (1.66, 2.6) <0.001 1.81 (1.44,
2.27)
<0.001
Study Design Features
Intervention Group
MedDiet + nuts 1962 1.00 (ref) 1.00 (ref) 1027 1.00 (ref) 1.00 (ref)
MedDiet + EVOO 2236 0.70 (0.62,
0.79)
<0.001 0.70 (0.62,
0.80)
<0.001 1326 0.74 (0.62,
0.87)
<0.001 0.74 (0.62,
0.88)
0.001
Total workload of center (person-
years) e,g
Q1 (low) 1247 1.00 (ref) 1.00 (ref) 624 1.00 (ref) 1.00 (ref)
Q2 1133 1.31 (1.12,
1.54)
1.34 (1.12,
1.59)
361 0.87 (0.70,
1.08)
0.87 (0.69,
1.10)
Q3 1168 1.90 (1.61,
2.23)
1.75 (1.46,
2.10)
804 0.67 (0.51,
0.87)
0.74 (0.56,
0.99)
Q4 (high) 650 1.32 (1.10,
1.60)
<0.001 1.48 (1.19,
1.79)
<0.001 564 2.56 (1.98,
3.31)
<0.001 2.27 (1.72,
3.00)
0.004
a ORs < 1 imply poorer adherence. ORs > 1 imply better adherence. A validated MedDiet adherence assessment tool was used. 1 point was added for each item in
adherence with the traditional MedDiet. High adherence = adherence with ≥11 items on 14-point dietary adherence score. Low adherence = adherence with <11
items. b All models are from logistic regression analysis. Multivariate models are mutually adjusted for all characteristics displayed in this table including total CVD
risk score but excluding individual CVD risk factors (type 2 diabetes, hypertension, hypercholesterolaemia, family history of pre-mature CHD, depression, obesity).
When an individual CVD risk factors was the exposure of interest, the model was mutually adjusted for other individual CVD risk factors but not total CVD risk
score. c P-values for trend were calculated by assigning the median value to each category and treating the resulting variable as continuous d Total CVD risk score
calculated by summing the following CVD risk factors: type 2 diabetes, hypertension, high blood cholesterol, family history of premature CHD, depression, obesity. e
Tertiles of physical activity (MET-min/d): T1: <108; T2: 108–268; T3: ≥268. f Quartiles of energy intake (kcal/d), by sex: Men: Q1: <2051; Q2: 2051- < 2394; Q3:2934- < 2801;
Q4: ≥2801. Women: Q1: <1786; Q2: 1786- < 2109; Q3: 2109- < 2465; Q4: ≥2465. g Measured in quartiles of person years at center. After 1 Year: Q1: 133- < 352; Q2: 352- <
537; Q3: 537- < 650; Q4: ≥650. After 4 years: Q1: 893- < 1220; Q2: 1220- < 2175; Q3: 2175- < 2384; Q4: ≥2384
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Table 3 Odds of high adherence with the MedDiet intervention every year throughout four years of follow-up. a
OR (95 % CI) for dietary adherence (≥11 vs. <11 points)b
Demographic Characteristics n Crude Model p Multivariate p
Sex
Men 815 1.00 (ref) 1.00 (ref)
Women 1103 0.69 (0.57, 0.84) <0.001 0.72 (0.49, 1.05) 0.09
Age at baseline (years)
< 65 683 1.00 (ref) 1.00 (ref)
≥ 65 1235 0.94 (0.77, 1.15) 0.57 0.85 (0.65, 1.12) 0.25
Educational level
University or higher 146 1.00 (ref) 1.00 (ref)
Secondary school 294 0.59 (0.39, 0.89) 0.01 0.71 (0.44, 1.14) 0.15
Primary School 1435 0.62 (0.44, 0.89) 0.006 0.78 (0.52, 1.18) 0.24
Less than primary school 43 0.23 (0.09, 0.57) 0.002 0.53 (0.19, 1.48) 0.23
Occupation
Retired 1017 1.00 (ref) 1.00 (ref)
Working 197 0.79 (0.56, 1.10) 0.16 0.72 (0.47, 1.11) 0.14
Housewife 662 0.85 (0.68, 1.05) 0.12 1.00 (0.72, 1.38) 0.98
Unemployed/unable to work 42 0.48 (0.22, 1.04) 0.06 0.72 (0.30, 1.71) 0.46
Marital Status
Married 1484 1.00 (ref) 1.00 (ref)
Single 76 1.04 (0.64, 1.71) 0.86 0.85 (0.47, 1.51) 0.58
Widowed 324 0.78 (0.60, 1.02) 0.07 0.89 (0.64, 1.24) 0.50
Divorced or separated 34 0.66 (0.29, 1.46) 0.30 1.35 (0.54, 3.40) 0.52
Number of people in household 1918 1.05 (0.96, 1.14) 0.31 1.02 (0.91, 1.14) 0.76
Health-Related Characteristics at Baseline
Number of CVD Risk Factors c,d
0–1 171 1.00 (ref) 1.00 (ref)
2 595 0.95 (0.67, 1.35) 1.13 (0.75, 1.68)
3 714 0.62 (0.44, 1.87) 0.91 (0.60, 1.37)
4 352 0.45 (0.30, 0.66) 0.78 (0.48, 1.25)
5–6 86 0.18 (0.08, 0.38) <0.001 0.27 (0.12, 0.63) 0.003
Type 2 Diabetes
No 993 1.00 (ref) 1.00 (ref)
Yes 925 0.63 (0.52, 0.77) <0.001 0.73 (0.56, 0.93) 0.01
Hypertension
No 367 1.00 (ref) 1.00 (ref)
Yes 1551 0.89 (0.70, 1.14) 0.36 0.75 (0.56, 1.02) 0.07
Hypercolesterolaemia
No 604 1.00 (ref) 1.00 (ref)
Yes 1314 1.04 (0.84, 1.28) 0.75 1.12 (0.87, 1.44) 0.39
Family history of premature CHD
No 1537 1.00 (ref) 1.00 (ref)
Yes 381 0.74 (0.57, 0.95) 0.02 0.72 (0.54, 0.97) 0.03
Depression
No 1607 1.00 (ref) 1.00 (ref)
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Table 3 Odds of high adherence with the MedDiet intervention every year throughout four years of follow-up. a (Continued)
Yes 311 0.72 (0.55, 0.95) 0.02 0.69 (0.50, 0.95) 0.02
Obesity
No 1054 1.00 (ref) 1.00 (ref)
Yes 864 0.57 (0.47, 0.70) <0.001 0.84 (0.63, 1.12) 0.23
SBP (per 5 mmHg) 1918 1.03 (1.01, 1.06) 0.004 1.02 (0.98, 1.05) 0.34
DBP (per 5 mmHg) 1918 1.04 (1.00, 1.09) 0.04 1.00 (0.94, 1.07) 0.94
Waist circumference (per 5 cm) 1918 0.82 (0.78, 0.87) <0.001 0.93 (0.88, 1.00) 0.04
Physical activity (MET-min/d) c,e
T1 (low) 552 1.00 (ref) 1.00 (ref)
T2 642 1.62 (1.24, 2.12) 1.27 (0.94, 1.71)
T3 (high) 724 2.63 (2.04, 3.40) <0.001 1.60 (0.18, 2.17) 0.002
Smoking Status
Never 1209 1.00 (ref) 1.00 (ref)
Former 251 1.04 (0.78, 1.41) 0.75 0.75 (0.51, 1.11) 0.15
Current 458 1.08 (0.86, 1.36) 0.51 0.82 (0.59, 1.14) 0.25
Total energy intake (kcal/day) c,f
Q1 (low) 405 1.00 (ref) 1.00 (ref)
Q2 443 1.11 (0.82, 1.50) 1.00 (0.71, 1.40)
Q3 499 1.37 (1.03, 1.82) 1.19 (0.84, 1.65)
Q4 (high) 571 1.15 (0.87, 1.53) 0.29 1.12 (0.80, 1.56) 0.39
Alcohol other than wine (g/day)
< 10 men, <5 women 1125 1.00 (ref) 1.00 (ref)
10-50 men, 5–10 women 270 1.25 (0.95, 1.65) 0.12 0.87 (0.61, 1.23) 0.43
> 50 men, >10 women 523 0.95 (0.75, 1.19) 0.63 0.95 (0.72, 1.25) 0.69
14-point adherence score a
< 11 1528 1.00 (ref) 1.00 (ref)
≥ 11 390 2.95 (2.34, 3.71) <0.001 2.63 (2.02, 3.42) <0.001
Study Design Features
Intervention Group
MedDiet + Nuts 809 1.00 (ref) 1.00 (ref)
MedDiet + EVOO 1109 0.68 (0.56, 0.82) <0.001 0.66 (0.53, 0.83) <0.001
Total workload of center (person-years) e,g
Q1 (low) 267 1.00 (ref) 1.00 (ref)
Q2 809 0.54 (0.39, 0.74) 0.56 (0.40, 0.80)
Q3 311 0.45 (0.30, 0.67) 0.52 (0.34, 0.80)
Q4 (high) 531 3.50 (2.55, 4.79) <0.001 3.17 (2.22, 4.52) <0.001
a ORs < 1 imply poorer adherence. ORs > 1 imply better adherence. A validated MedDiet adherence assessment tool was used. 1 point was added for each item in
adherence with the traditional MedDiet. High adherence = adherence with ≥11 items on 14-point dietary adherence score. Low adherence = adherence with <11 items.
b All models are from logistic regression analysis. Multivariate models are mutually adjusted for all characteristics displayed in this table including total CVD risk score
but excluding individual CVD risk factors (type 2 diabetes, hypertension, hypercholesterolaemia, family history of pre-mature CHD, depression, obesity). When an
individual CVD risk factors was the exposure of interest, the model was mutually adjusted for other individual CVD risk factors but not total CVD risk score. c P-values for
trend were calculated by assigning the median value to each category and treating the resulting variable as continuous. d Risk score calculated by summing the
following CVD risk factors: type 2 diabetes, hypertension, high blood cholesterol, family history of premature CHD, depression, obesity. e Tertiles of physical activity
(MET-min/d): T1: <108; T2: 108–268; T3: ≥268. f Quartiles of energy intake (kcal/d), by sex: Men: Q1: <2051; Q2: 2051- < 2394; Q3:2934- < 2801; Q4: ≥2801. Women: Q1:
<1786; Q2: 1786- < 2109; Q3: 2109- < 2465; Q4: ≥2465. g Measured in quartiles of person years at center. After 4 years: Q1: 893- < 1220; Q2: 1220- < 2175; Q3: 2175- <
2384; Q4: ≥2384
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and/or habits; the time during which one is more
motivated to make improvements may have passed.
Regardless, unhealthy individuals have a greater need
for dietary improvement. Thus, they are often the
most important targets of dietary interventions. Per-
sonalized, higher-intensity intervention approaches
may be needed to achieve optimal adherence among
less healthy individuals.
Demographic characteristics
Like this study, most previous studies [35, 37] found that
women have lower adherence than men. The only excep-
tion was a family intervention study [34]. It is possible that
because mothers traditionally plan family meals, they were
motivated to set a positive example through intervention
adherence [34]. However, in this study population, it is
possible that spouses and children influence meal prepar-
ation, leading to these disparate findings. Different strat-
egies likely have different levels of effectiveness based on
sex [54]. However, in the present study the female sex only
predicted lower adherence at one year of follow-up, and
not four years.
There have been conflicting findings about the rela-
tionship between age and dietary adherence [27, 29, 37].
The age range in the present study was restricted to 55–
80 years; hence little age variability likely limited the
ability to detect an association.
There was little evidence for an association between edu-
cational attainment and intervention adherence. While par-
ticipants with less than a primary school education had
lower long-term adherence than those with university level
or higher, this did not hold in several sensitivity analyses.
Previous studies have found that higher socioeconomic sta-
tus predicted better dietary adherence, but findings did not
hold for long-term adherence [27, 29] and were limited to
low-fat dietary interventions [33]. This suggests that dietary
interventions may be able to overcome the socioeconomic
disparities that often exist in nutrition [55].
Further discussion
The present study has several strengths. First, the sample
size was large and it was conducted in an established,
long-term, and successful randomized trial. Second, be-
cause all study participants were at high risk for CVD, it
was possible to assess adherence among participants who
were less healthy compared to the general population. Be-
cause they also were likely to have poorer baseline diets,
adherence was probably especially challenging for these
individuals. Thus, significant predictors of adherence may
be even more meaningful in this setting. Third, this is one
of the few studies that has been able to assess long-term
dietary adherence. This is critical, as long-term, high-
quality dietary pattern is the relevant dietary exposure for
the prevention of chronic disease. Fourth, mutually
adjusting for a wide array of baseline characteristics mini-
mized residual confounding. Lastly, significant measure-
ment error is unlikely because only 0.3 % of covariate
values were missing, a validated measure for assessing
dietary adherence was used [46], and previous analyses
show that self-reported dietary intake is highly correlated
with biomarkers in this population [18, 23].
It is important to note that because the high adher-
ence is not rare, the ORs do not approximate risk ratios
(RRs) and thus should not be incorrectly interpreted
as RRs. However, provided appropriate interpretation,
ORs still provide valid estimates, and it is more ap-
propriate to apply OR estimates to all individuals
within a population. Furthermore, because an OR in-
corporates both success and failure symmetrically, it
is less arbitrary than a RR and thus a more robust es-
timate [56].
There are also limitations in this study. The poten-
tial for measurement error always exists. To include
as many people as possible in the present analyses,
missing covariate values were imputed for 0.3 % of
values. Recall bias, social desirability bias and differ-
ential misreporting are always possible when diet is
self-reported. Finally, it is always possible that failure
to control for unmeasured confounders may have
distorted results for predictors of dietary adherence.
However, analyses were adjusted for a wide array of
important baseline characteristics, and a strong con-
founder unrelated to these characteristics is unlikely.
This unique population of older Spanish participants
at high risk for cardiovascular disease may have low
generalizability to the general public at lower risk of
CVD.
The relative success of a dietary intervention to induce
changes in the overall food pattern has been more fre-
quently ascribed to strategies related to negotiation, goal
setting, self monitoring, and skill building [57–59].
Other strategies such as the training of dietitians, length
and intensity of intervention, frequency of contacts,
multiplicity of channels used for the delivery of the
intervention, the initial motivation of participants for ad-
herence, and the provision of appropriate means for
feedback should not be forgotten.
It is clear that certain participants have greater diffi-
culty complying with dietary interventions. Our results
identify specific baseline characteristics that predict
better adherence, which is an instrumental first step for
designing personalized intervention delivery strategies.
However, further research is needed to also identify
barriers to dietary adherence. Identifying both individ-
ual and universal barriers will have important implica-
tions for exactly how to promote adherence, and allow
for an even more targeted and personalized interven-
tion approach.
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Conclusion
Investigators should design dietary interventions for max-
imum dietary adherence. Long-term adherence is especially
important. With a growing worldwide interest in interven-
tions promoting the MedDiet, these results suggest the
need for an early identification of participants with lower
baseline adherence to a healthy diet and poorer health sta-
tus. Additional efforts to promote adherence might be re-
quired among this group. Further research is needed to
identify the most effective approach for overcoming the in-
herent difficulties in achieving optimal adherence, including
identifying barriers to dietary change and adherence at an
individual level. For multi-centered studies, it may be more
effective to streamline intervention delivery by allocating
participants to few large centers rather to many small cen-
ters; a higher volume of participants per dietitian in these
large center will be more effective to obtain adherence.
Dietary intervention studies designed to maximize adher-
ence will contribute higher quality public health research
and generate more effective and permanent dietary im-
provements among participants. This will ultimately
decrease the burden of diet-related non-communicable
diseases.
Additional files
Additional file 1: Table S1. Odds of high adherence with the MedDiet
intervention at two and three years of follow-up. Table S2. Odds of high
adherence with the MedDiet intervention using alternate adherence
score cut-points. Table S3. Odds of adherence with olive oil and nut
consumption after 1 and 4 years of follow-up. Table S4. Odds of high
adherence with the MedDiet intervention at one yeara, restricting the
analyses to those participants recruited before 2006. Table S5.
Adherence at one year of follow-up according to a 14-point dietary
adherence score and year of recruitment into PREDIMED. Table S6. Odds
of high adherence with the MedDiet intervention at one and four years
of follow-upa, with alternate representation of “total workload”.
(DOC 615 kb)
Additional file 2: Figure S1. Validated 14-item questionnaire of
mediterranean diet adherence (DOCX 205 kb)
Additional file 3: Consort 2010 Checklist. (DOC 219 kb)
Abbreviations
CHD, coronary heart disease; DBP, diastolic blood pressure; FFQ, food
frequency questionnaire; MedDiet, Mediterranean-type diet; MET, metabolic
equivalent of task; OR, odds ratio; PREDIMED, PREvención con DIeta MEDiter-
ránea; RCTs, randomized controlled trials; RR, risk ratio; SBP, systolic blood
pressure; SD, standard deviation
Acknowledgements
N/A-everyone included in author list and funding section.
Funding
This study was funded by the Spanish Ministry of Health (ISCIII), PI1001407,
Thematic Network G03/140, RD06/0045, FEDER (Fondo Europeo de
Desarrollo Regional), and the Centre Català de la Nutrició de l’Institut
d’Estudis Catalans. The Fundación Patrimonio Comunal Olivarero and
Hojiblanca SA (Málaga, Spain), California Walnut Commission (Sacramento,
CA), Borges SA (Reus, Spain), and Morella Nuts SA (Reus, Spain) donated the
olive oil, walnuts, almonds and hazelnuts, respectively, used in the study.
CIBEROBN is an initiative of ISCIII, Spain.
Availability of data and materials
If you do not wish to share your data, please state that data will not be
shared, and state the reason. Due to PREDIMED confidentiality policies, data
will not be shared.
Authors’ contributions
MKD, AG, MAMG designed the research. MKD conducted the research. MKD,
AG, MAMG analyzed the data. MKD wrote the paper, with guidance and
editing from AG, MAMG, MJ. AST was a primary PREDIMED dietitian. MAMG,
DC, JSS, ER, RE, MF, EG-G, FA, ML, FJG, LSM, XP, JB, JVS, EV, SLM, XP, JB, EV
were coordinators of subject recruitment. IZ assisted with administrative
logistics. MKD, AG, MAMG had full access to all the data and the study and
take responsibility for the integrity of the analysis. All authors revised the
manuscript. All authors read and approved the final manuscript.
Authors’ information
N/A
Competing interests
The authors declare that they have no competing interests. None of the
funding sources played a role in the design, collection, analysis or
interpretation of the data or in the decision to submit the manuscript for
publication.
Consent for publication
Not Applicable.
Ethics approval and consent to participate
During enrollment, investigators conducted face-to-face interviews with
potential participants, during which the purpose and characteristics of the
study were explained and informed consent was obtained from willing
participants. The International Review Board (IRB) of Hospital Clinic in
Barcelona, Spain, approved the study protocol in July 2002. Following this,
IRBs of all other centers approved. Participants were randomized to one of
three interventions after providing written consent. No harm or unintended
effects were reported in any arm [40].
Author details
1Department of Epidemiology, Harvard T.H. Chan School of Public Health,
677 Huntington Avenue, Boston, MA 02115, USA. 2Department of Preventive
Medicine and Public Health, Faculty of Medicine, University of Navarra, C/
Irunlarrea, No. 1. Research Building, 2nd floor, Local 2520, 31008 Pamplona,
Navarra, Spain. 3Channing Division of Network Medicine, 181 Longwood
Avenue, Room 345, Boston, MA 02115, USA. 4Department of Preventive
Medicine, University of Valencia, AVDA,Vicente Blasco Ibanez, 15, 46010
Valencia, Spain. 5Human Nutrition Unit, Biochemistry and Biotechnology
Department, IISPV, Hospital Universitari de Sant Joan de Reus, Universitat
Rovira i Virgili, C/Sant Llorenç, 21, 43201 Reus, Spain. 6Lipid Clinic,
Department of Endocrinology and Nutrition, Institut d’Investigacions
Biomediques August Pi Sunyer (IDIBAPS), Hospital Clinic, University of
Barcelona, C/Villarroel, 170, 08036 Barcelona, Spain. 7Department of Internal
Medicine, Institut d’Investigacions Biomediques August Pi Sunyer (IDIBAPS),
Hospital Clinic, University of Barcelona, C/Villarroel, 170, 08036 Barcelona,
Spain. 8Cardiovascular and Nutrition Research Group, Institut de Recerca
Hospital del Mar, Carrer Dr. Aiguader, 88, 08003 Barcelona, Spain.
9Department of Preventive Medicine, University of Malaga, Campus de
Teatinos, 29071 Malaga, Spain. 10Department of Cardiology, University
Hospital of Araba, C/Jose Atxotegi, s/n, 01009 Vitoria-Gasteiz, Araba, Spain.
11Palma Institute of Health Research (IdISPa), University of Balearic Islands
and Hospital Son Espases, Carretera de Valldemossa, 79, 07120 Palma, Illes
Balears, Spain. 12Department of Family Medicine, Research Unit, Distrito
Sanitario Atencion Primaria Sevilla, Avda. de Jerez s/n, 41007 Sevilla, Spain.
13Research Institute of Biomedical and Health Sciences, University of Las
Palmas de Gran Canaria, Juan De Quesada 30, 35001 Las Palmas, Spain.
14Head of Lipid and Vascular Risk Unit, Internal Medicine Department,
Hospital Universitari de Bellvitge-IDIBELL. Universidad de Barcelona, C/Freixa
Larga s/n, 08907 - Hospitalet de Llobregat, Barcelona, Spain. 15Human
Nutrition Unit, Biochemistry and Biotechnology Department, IISPV Universitat
Rovira i Virgili, C/Sant Llorenç, 21 Planta baja del edificio 4 de la Facultat de
Medicina i Ciències de la Salut, 43201 Reus, Tarragona, Spain. 16Jordi Gol
Primary Care Research Institute, Gran Via de les Corts Catalanes 587, àtic,
Downer et al. International Journal of Behavioral Nutrition and Physical Activity  (2016) 13:67 Page 14 of 16
08007 Barcelona, Spain. 17Centro de Investigación Biomédica en Red
Fisiopatología de la Obesidad y Nutrición (CIBERobn), Instituto de Salud
Carlos III, 28029 Madrid, Spain. 18IdiSNA, Navarra Institute por Health
Research, 31008 Barcelona, Navarra, Spain.
Received: 22 April 2016 Accepted: 7 June 2016
References
1. Ng M, Fleming T, Robinson M, et al. Global, regional, and national
prevalence of overweight and obesity in children and adults during 1980–
2013: a systematic analysis for the global burden of disease study 2013.
Lancet. 2014;384(9945):766–81.
2. Popkin BM, Adair LS, Ng SW. Global nutrition transition and the pandemic
of obesity in developing countries. Nutr Rev. 2012;70(1):3–21.
3. Mitrou PN, Kipnis V, Thiebaut AC, et al. Mediterranean dietary pattern and
prediction of all-cause mortality in a US population: results from the NIH-
AARP Diet and Health Study. Arch Intern Med. 2007;167(22):2461–8.
4. Sofi F, Macchi C, Abbate R, Gensini GF, Casini A. Mediterranean diet and
health status: an updated meta-analysis and a proposal for a literature-
based adherence score. Public Health Nutr. 2014;17(12):2769–82.
5. van den Brandt PA. The impact of a Mediterranean diet and healthy
lifestyle on premature mortality in men and women. Am J Clin Nutr.
2011;94(3):913–20.
6. Tyrovolas S, Panagiotakos DB. The role of Mediterranean type of diet on the
development of cancer and cardiovascular disease, in the elderly: a
systematic review. Maturitas. 2010;65(2):122–30.
7. Chiva-Blanch G, Badimon L, Estruch R. Latest evidence of the effects of the
Mediterranean diet in prevention of cardiovascular disease. Curr Atheroscler
Rep. 2014;16(10):446.
8. Sleiman D, Al-Badri MR, Azar ST. Effect of mediterranean diet in diabetes
control and cardiovascular risk modification: a systematic review. Front
Public Health. 2015;3:69.
9. Koloverou E, Esposito K, Giugliano D, Panagiotakos D. The effect of
Mediterranean diet on the development of type 2 diabetes mellitus: a
meta-analysis of 10 prospective studies and 136,846 participants.
Metabolism. 2014;63(7):903–11.
10. Beunza JJ, Toledo E, Hu FB, et al. Adherence to the Mediterranean diet,
long-term weight change, and incident overweight or obesity: the
Seguimiento Universidad de Navarra (SUN) cohort. Am J Clin Nutr. 2010;
92(6):1484–93.
11. Vadivel V, Kunyanga CN, Biesalski HK. Health benefits of nut consumption with
special reference to body weight control. Nutrition. 2012;28(11–12):1089–97.
12. Benetou V, Trichopoulou A, Orfanos P, et al. Conformity to traditional
Mediterranean diet and cancer incidence: the Greek EPIC cohort. Br J
Cancer. 2008;99(1):191–5.
13. Schwingshackl L, Hoffmann G. Adherence to Mediterranean diet and risk of
cancer: a systematic review and meta-analysis of observational studies. Int J
Cancer. 2014;135(8):1884–97.
14. Esposito K, Giugliano D. Mediterranean diet and type 2 diabetes. Diabetes
Metab Res Rev. 2014;30 Suppl 1:34–40.
15. Esposito K, Kastorini CM, Panagiotakos DB, Giugliano D. Mediterranean diet
and weight loss: meta-analysis of randomized controlled trials. Metab Syndr
Relat Disord. 2011;9(1):1–12.
16. Martinez-Gonzalez MA, de la Fuente-Arrillaga C, Nunez-Cordoba JM, et al.
Adherence to Mediterranean diet and risk of developing diabetes:
prospective cohort study. BMJ. 2008;336(7657):1348–51.
17. Di Daniele N, Petramala L, Di Renzo L, et al. Body composition changes and
cardiometabolic benefits of a balanced Italian Mediterranean Diet in obese
patients with metabolic syndrome. Acta Diabetol. 2013;50(3):409–16.
18. Estruch R, Martinez-Gonzalez MA, Corella D, et al. Effects of a
Mediterranean-style diet on cardiovascular risk factors: a randomized trial.
Ann Intern Med. 2006;145(1):1–11.
19. Martinez-Gonzalez MA, Guillen-Grima F, De Irala J, et al. The Mediterranean
diet is associated with a reduction in premature mortality among middle-
aged adults. J Nutr. 2012;142(9):1672–8.
20. Dietary Gudielines for Americans: 2015–2020. Eighth Edition. 2015. http://
health.gov/dietaryguidelines/2015/guidelines/. Accessed 19 April 2016.
21. Inelmen EM, Toffanello ED, Enzi G, et al. Predictors of drop-out in
overweight and obese outpatients. Int J Obes (Lond). 2005;29(1):122–8.
22. Douketis JD, Macie C, Thabane L, Williamson DF. Systematic review of long-
term weight loss studies in obese adults: clinical significance and
applicability to clinical practice. Int J Obes (Lond). 2005;29(10):1153–67.
23. Zazpe I, Sanchez-Tainta A, Estruch R, et al. A large randomized individual
and group intervention conducted by registered dietitians increased
adherence to Mediterranean-type diets: the PREDIMED study. J Am Diet
Assoc. 2008;108(7):1134–44. discussion 1145.
24. Tuomilehto J, Lindstrom J, Eriksson JG, et al. Prevention of type 2 diabetes
mellitus by changes in lifestyle among subjects with impaired glucose
tolerance. N Engl J Med. 2001;344(18):1343–50.
25. Howard BV, Van Horn L, Hsia J, et al. Low-fat dietary pattern and risk of
cardiovascular disease: the Women's health initiative randomized controlled
dietary modification trial. JAMA. 2006;295(6):655–66.
26. Knowler WC, Barrett-Connor E, Fowler SE, et al. Reduction in the incidence
of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med.
2002;346(6):393–403.
27. Tinker LF, Rosal MC, Young AF, et al. Predictors of dietary change and
maintenance in the Women's health initiative dietary modification trial. J
Am Diet Assoc. 2007;107(7):1155–66.
28. McClain AD, Otten JJ, Hekler EB, Gardner CD. Adherence to a low-fat vs.
low-carbohydrate diet differs by insulin resistance status. Diabetes Obes
Metab. 2013;15(1):87–90.
29. Women's Health Initiative Study G. Dietary adherence in the Women's health
initiative dietary modification trial. J Am Diet Assoc. 2004;104(4):654–8.
30. Pijls LT, de Vries H, van Eijk JT, Donker AJ. Adherence to protein restriction
in patients with type 2 diabetes mellitus: a randomized trial. Eur J Clin Nutr.
2000;54(4):347–52.
31. Steptoe A, Perkins-Porras L, Rink E, Hilton S, Cappuccio FP. Psychological
and social predictors of changes in fruit and vegetable consumption over
12 months following behavioral and nutrition education counseling. Health
Psychol. 2004;23(6):574–81.
32. Epstein DE, Sherwood A, Smith PJ, et al. Determinants and consequences of
adherence to the dietary approaches to stop hypertension diet in African-
American and white adults with high blood pressure: results from the
ENCORE trial. J Acad Nutr Diet. 2012;112(11):1763–73.
33. Alhassan S, Kim S, Bersamin A, King AC, Gardner CD. Dietary adherence and
weight loss success among overweight women: results from the A TO Z
weight loss study. Int J Obes (Lond). 2008;32(6):985–91.
34. Aggarwal B, Liao M, Allegrante JP, Mosca L. Low social support level is
associated with non-adherence to diet at 1 year in the Family Intervention
Trial for Heart Health (FIT Heart). J Nutr Educ Behav. 2010;42(6):380–8.
35. Zazpe I, Estruch R, Toledo E, et al. Predictors of adherence to a
Mediterranean-type diet in the PREDIMED trial. Eur J Nutr. 2010;49(2):91–9.
36. Wang JB, Pierce JP, Ayala GX, et al. Baseline depressive symptoms,
completion of study assessments, and behavior change in a long-term
dietary intervention among breast cancer survivors. Ann Behav Med. 2015;
49(6):819–27.
37. Bautista-Castano I, Molina-Cabrillana J, Montoya-Alonso JA, Serra-Majem
L. Variables predictive of adherence to diet and physical activity
recommendations in the treatment of obesity and overweight, in a
group of Spanish subjects. Int J Obes Relat Metab Disord. 2004;28(5):
697–705.
38. Martinez-Gonzalez MA, Salas-Salvado J, Estruch R, et al. Benefits of the
mediterranean diet: insights from the PREDIMED study. Prog Cardiovasc Dis.
2015;58(1):50–60.
39. Parekh N, Zizza C. Life course epidemiology in nutrition and chronic disease
research: a timely discussion. Adv Nutr. 2013;4(5):551–3.
40. Willett WC, Koplan JP, Nugent R, Dusenbury C, Puska P, Gaziano TA.
Prevention of chronic disease by means of diet and lifestyle changes. In:
Jamison DT, Breman JG, Measham AR, et al., editors. Disease control
priorities in developing countries. 2nd ed. Washington DC: World Bank;
2006.
41. Estruch R, Ros E, Salas-Salvado J, et al. Primary prevention of cardiovascular
disease with a Mediterranean diet. N Engl J Med. 2013;368(14):1279–90.
42. Martinez-Gonzalez MA, Corella D, Salas-Salvado J, et al. Cohort profile:
design and methods of the PREDIMED study. Int J Epidemiol. 2012;41(2):
377–85.
43. Salas-Salvado J, Garcia-Arellano A, Estruch R, et al. Components of the
Mediterranean-type food pattern and serum inflammatory markers among
patients at high risk for cardiovascular disease. Eur J Clin Nutr. 2008;62(5):
651–9.
Downer et al. International Journal of Behavioral Nutrition and Physical Activity  (2016) 13:67 Page 15 of 16
44. World Medical Association General A. World medical association declaration
of Helsinki: ethical principles for medical research involving human subjects.
J Int Bioethique. 2004;15(1):124–9.
45. Martinez-Gonzalez MA, Garcia-Arellano A, Toledo E, et al. A 14-item
Mediterranean diet assessment tool and obesity indexes among high-risk
subjects: the PREDIMED trial. PLoS One. 2012;7(8), e43134.
46. Schroder H, Fito M, Estruch R, et al. A short screener is valid for assessing
Mediterranean diet adherence among older Spanish men and women. J
Nutr. 2011;141(6):1140–5.
47. Fernandez-Ballart JD, Pinol JL, Zazpe I, et al. Relative validity of a semi-
quantitative food-frequency questionnaire in an elderly Mediterranean
population of Spain. Br J Nutr. 2010;103(12):1808–16.
48. Willett WC. Nutritional epidemiology. 3rd ed. New York: Oxford University
Press; 2013.
49. Elosua R, Marrugat J, Molina L, Pons S, Pujol E. Validation of the Minnesota
leisure time physical activity questionnaire in spanish men. The MARATHOM
investigators. Am J Epidemiol. 1994;139(12):1197–209.
50. Elosua R, Garcia M, Aguilar A, Molina L, Covas MI, Marrugat J. Validation of
the Minnesota leisure time physical activity questionnaire in spanish
women. Investigators of the MARATDON group. Med Sci Sports Exerc. 2000;
32(8):1431–7.
51. Artigao LM, Llavador JJ, Puras A, et al. Evaluation and validation of Omron
Hem 705 CP and Hem 706/711 monitors for self-measurement of blood
pressure. Aten Primaria. 2000;25(2):96–102.
52. Canto JG, Every NR, Magid DJ, et al. The volume of primary angioplasty
procedures and survival after acute myocardial infarction. National Registry
of Myocardial Infarction 2 Investigators. N Engl J Med. 2000;342(21):1573–80.
53. Lawson PJ, Flocke SA. Teachable moments for health behavior change: a
concept analysis. Patient Educ Couns. 2009;76(1):25–30.
54. De Bourdeaudhuig I, va Oost P. Family members' influence on decision
making about food: differences in perception and relationship with healthy
eating. Am J Health Promot. 1998;13(2):73–81.
55. Drewnowski A, Darmon N. The economics of obesity: dietary energy density
and energy cost. Am J Clin Nutr. 2005;82(1 Suppl):265S–73.
56. Cook TD. Advanced statistics: Up with odds ratios! a case for odds ratios
when outcomes are common. Acad Emerg Med. 2002;9:1430–4.
57. Papadaki A, Wood L, Sebire SJ, Jago R. Adherence to the Mediterranean diet
among employees in South West England: Formative research to
inform a web-based, work-place nutrition intervention. Prev Med Rep.
2015;29(2):223–8.
58. Bravata DM, Sanders L, Huang J, et al. Efficacy and safety of low-
carbohydrate diets: a systematic review. JAMA. 2003;289:1837–50.
59. McCahon D, Daley AJ, Jones J, Haslop R, Shajpal A, Taylor A, Wilson S,
Dowswell G. Enhancing adherence in trials promoting change in diet and
physical activity in individuals with a diagnosis of colorectal adenoma; a
systematic review of behavioural intervention approaches. BMC Cancer.
2015;7(15):505.
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
Downer et al. International Journal of Behavioral Nutrition and Physical Activity  (2016) 13:67 Page 16 of 16
